Connect with us

Technology

Prime/MRx’s new Pharmacy Match technology-driven solution expands specialty pharmacy access and choice

Published

on

Using real-time pricing, Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member

EAGAN, Minn., June 19, 2024 /PRNewswire/ — Prime Therapeutics LLC and Magellan Rx Management (Prime/MRx) today launched Pharmacy Match, a technology-enabled specialty pharmacy solution designed to drive competition through an expanded specialty pharmacy network and to lower drug costs for plan sponsors.

Specialty drugs remain the fastest-growing area of pharmacy spend, accounting for more than half of the total pharmaceutical market today.1 That share is skyrocketing, driven by price increases and the introduction of new treatments,2 further threatening affordability for stakeholders. The inherent fragmentation and complexity in the specialty pharmacy space exacerbates these issues, hindering patient access to necessary therapies and complicating efforts to manage costs effectively in an evolving market.

Pharmacy Match further amplifies Prime/MRx’s distinctive conflict-free approach to the prescription drug supply chain model by offering members access to a broader network of quality specialty pharmacies, reducing reliance on any single pharmacy partner and promoting real-time competition. Another distinguishing feature is that Pharmacy Match is complementary to other existing Prime/MRx programs, including IntegratedRx® with a proven industry-leading 95% satisfaction rating.

“Providing access to rapidly expanding specialty treatments while controlling cost is one of the biggest challenges facing health care today,” said Nathan Downhour, senior vice president, pharmacy and care solutions at Prime/MRx. “Pharmacy Match is one example of how we are working to expand access to affordable medications while helping members navigate their specialty journey.”

Pharmacy Match, powered by Free Market Health‘s proprietary, cloud-based technology platform, helps members smoothly flow through their specialty journey. To help create a frictionless experience, the real-time referral feature comparison shops the market and helps ensure members’ specialty medications are provided by the specialty pharmacy best suited to meet their needs. And to help alleviate uncertainty, Pharmacy Match members who are new to therapy are engaged early to help ensure an uninterrupted journey. Through this platform, each specialty claim is tracked to fulfillment, elevating the experience for plan sponsors and their members.

“Our technology platform is a proven flexible solution that delivers plan sponsors unprecedented control over their specialty drug management programs, enabling them to efficiently balance the cost of care with the value that care provides in their unique markets,” said Joe Cardosi, founder and CEO of Free Market Health. “We’re excited to partner with Prime as we share a common goal of streamlining the fragmented drug delivery system so patients can seamlessly start and continue their specialty drug treatments to achieve the best possible outcomes.”

“Prime/MRx’s priority is to improve the specialty pharmacy ecosystem. We envision an intelligently designed, technology-enabled specialty care model that improves the experience for members, from prescription intake to fulfillment, while eliminating complexities, driving savings and reducing waste,” Downhour added. “Pharmacy Match is our first step toward this vision.”

To understand how Prime/MRx is charting a different path than its competition and creating a new standard for the pharmacy-solutions industry, visit primetherapeutics.com.

About Prime Therapeutics + Magellan Rx
Prime Therapeutics LLC is a diversified pharmacy solutions organization serving health plans, employers and government programs. Magellan Rx Management, LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together, Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information, visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

About Free Market Health
Founded in 2019 and headquartered in Pittsburgh, Free Market Health partners with forward-thinking payers and specialty pharmacies of all sizes to streamline the complex and opaque specialty medication fulfillment process to ensure patients have prompt access to lifesaving and life-altering medications. Free Market Health opens up a dynamic, care-driven marketplace that empowers its stakeholders to optimize resources and maximize opportunities with the goal of balancing the cost of care and the value that care provides. Learn more at www.freemarkethealth.com.

1. Insights Into the 2023 U.S. Pharmaceutical Market. IQVIA. Accessed May 20, 2024.
2. U.S. Insights: January 2024 Drug Price Changes. IPD Analytics. March 2024.

Contact:     

Jenine Anderson

Public Relations Manager

612.777.5629

Jenine.anderson@primetherapeutics.com

View original content:https://www.prnewswire.com/news-releases/primemrxs-new-pharmacy-match-technology-driven-solution-expands-specialty-pharmacy-access-and-choice-302176824.html

SOURCE Prime Therapeutics LLC

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bloomberg Accelerates Financial Analysis with Gen AI Document Insights

Published

on

By

Research Analysts & Corporate Decision Makers Can Ask Complex Questions within Company Documents

NEW YORK, April 7, 2025 /PRNewswire/ — Bloomberg today announced the launch of AI-Powered Document Insights which uses generative AI to make it easier for research analysts and corporate decision makers to quickly surface insights from a company document by asking questions in everyday conversational language. This innovative research solution is an evolution of Bloomberg’s AI-Powered Earnings Call Summaries, complements AI-Powered News Summaries, and links seamlessly with Bloomberg’s other purpose-built analytical tools and workflows as part of the company’s mission to reimagine the Bloomberg Terminal for the age of AI.

AI-Powered Document Insights provides users with robust search and summarization capabilities made possible by Bloomberg’s decades of expertise and more than 15 years of leadership in applying AI in the financial domain. Bloomberg Intelligence analysts helped train the generative AI models so they more accurately understand the nuances of financial language by using Bloomberg’s AI guardrail systems. The research solution enables customers to adjust their positions and investment views on a company by quickly analyzing text and structured data within a company document from a vast library of trusted and premium content. This research library on the Bloomberg Terminal includes more than 200 million company documents, more than 5,000 Bloomberg News stories published each day on the markets, economies, industries, and companies that matter, as well as research content like Bloomberg Intelligence reports which cover thousands of companies.

Magdalena Richardson, Credit Trading Strategist at NatWest Markets Plc, said: “What I like about AI-Powered Document Insights is that it provides a great summary of a company’s comments when asked a direct question. For example, within an earnings call transcript for an original equipment manufacturer, the solution can be asked about the impact of tariffs. I think this solution is a godsend on a day when you have multiple earnings calls and cannot attend them all or need to revisit a topic.”

Thymen Rundberg, Equity Research Associate at ING, said: “What I find valuable is that AI-Powered Document Insights allows me to quickly find specific information within earnings call transcripts, saving me time versus manually searching through the document. The tool also allows me to stay up to date with more peers of companies in my coverage. This was definitely a more tedious task before.”

Bloomberg will continue to use generative AI to enhance research solutions like AI-Powered Document Insights with additional document coverage, product features and integrations to help customers discover more answers and actionable insights with a user experience that is easy and comprehensive. Click here to request to join the beta program for our future research solutions enhanced by generative AI. 

Starting today, customers can explore the new interface and its features like ‘Ask a Question’, where users can either explore their hypothesis about developing investment themes like “tariffs” or retrieve specific information like “procurement costs.” The feature covers company documents and transcripts for earnings calls, conference presentations, investor days, capital markets days, shareholder meetings, M&A calls, sales results calls, guidance calls, and more. The solution also incorporates transparency links to highlight relevant excerpts in the original document and audio replays to hear the tone and tenor of executives and corporate spokespeople. ‘Key Notes’ provides a structured overview of Bloomberg selected topics raised in company presentations.

Suzanne Szur, Research and Companies Product Manager at Bloomberg, said: “With AI-Powered Document Insights, we’re delivering our customers a solution that is infused with financial domain knowledge. It’s been developed in close collaboration with our customers and evaluated by our team of product, data and technology experts who understand the importance of responsible AI down to the design features. Very soon we’ll launch additional research solutions to help financial professionals and their teams find unique insights, improve their research methods, and develop investment strategies tailored to various time horizons in this uncertain macro environment.”

Bloomberg’s research solutions help transform the investment research and analysis process so clients can add actionable resources to their data and tech stacks for single-desktop and enterprise-wide use. Clients can optimize their research offering so that trusted and consistent data is deeply integrated into research and production workflows throughout their enterprise, and their unique views are quickly distributed to counterparties. Bloomberg’s research solutions provide organizations access to consistent, high-quality data and analytics from Bloomberg as well as hundreds of valued content partners.

For teams of quants, research analysts and data scientists, Investment Research Data products offer end-to-end solutions to power workflows across the enterprise. This enables firms to test their investment hypotheses rigorously with granular data across asset classes and deep point-in-time history. The datasets are seamlessly interconnected with other content, including alternative data for both public and private companies, and available via a number of flexible delivery mechanisms, including the cloud. Bloomberg’s Research Management Solutions (RMS) Platform is also designed to optimize the research process by driving front-office efficiency, facilitating collaboration around ideas and throughout the investment lifecycle. Bloomberg’s RMS is also interoperable with Bloomberg’s other enterprise products, including portfolio and risk analytics offerings and leading order and investment management technology solutions, for a more comprehensive, end-to-end workflow.

About AI at Bloomberg
Since 2009, Bloomberg has been building and using artificial intelligence (AI) in the finance domain – including machine learning (ML), natural language processing (NLP), information retrieval (IR), time-series analysis, and generative models – to help process and organize the ever-increasing volume of structured and unstructured financial information. With this technology, Bloomberg is developing new ways for financial professionals and business leaders to derive valuable intelligence and actionable insights from high-quality financial information and make more informed business decisions.

About the Bloomberg Terminal
For more than four decades, the Bloomberg Terminal has revolutionized the financial services industry by bringing transparency and innovation to the capital markets. Trusted by the world’s most influential decision-makers, the Terminal provides real-time access to news, data, insights and trading tools that help our customers turn knowledge into action.

About Bloomberg
Bloomberg is a global leader in business and financial information, delivering trusted data, news, and insights that bring transparency, efficiency, and fairness to markets. The company helps connect influential communities across the global financial ecosystem via reliable technology solutions that enable our customers to make more informed decisions and foster better collaboration. For more information, visit Bloomberg.com/company or request a demo.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bloomberg-accelerates-financial-analysis-with-gen-ai-document-insights-302421875.html

SOURCE Bloomberg L.P.

Continue Reading

Technology

ZERO INDUSTRIAL ANNOUNCES $10 MILLION SERIES A INVESTMENT TO ACCELERATE DEVELOPMENT OF THERMAL ENERGY STORAGE IN NORTH AMERICA

Published

on

By

CHARLESTON, S.C., April 7, 2025 /PRNewswire/ — Zero Industrial, Inc. (“Zero Industrial”), a leading development company decarbonizing industrial heat by utilizing thermal energy storage (“TES”) systems, announced today that it successfully closed $10 million in funding led by Evok Innovations (“Evok”) with participation from Rusheen Capital Management (“Rusheen”).

“We are excited to partner with Evok and Rusheen to help us accelerate the deployment of thermal energy storage projects in North America,” said Ted Kniesche, founder and CEO. “We are rapidly originating project opportunities with industrial customers who want to reduce their energy costs and lower their carbon footprint by using stored electricity as thermal energy, instead of burning gas, fuel oil or coal.”

Zero Industrial was founded in 2024 by Ted Kniesche and Jim McDermott to decarbonize industrial heat using commercially-available TES systems at industrial facilities. The company provides full project development services to its customers, including technology selection, project design and engineering of each TES system. Importantly, Zero Industrial will fully finance each project and sell clean heat or steam to its customers under a long-term Heat-as-a-Service contract without any upfront capital outlay required by the industrial facility. 

“We are excited to partner with Ted and his team at Zero Industrial to build a market leading development business that will accelerate the decarbonization of industry – one of the hardest to abate sectors of our economy,” said Naynika Chaubey, Partner at Evok Innovations. “We continue to see massive growth from cheap, intermittent renewable generation, coupled with increasingly impacted electrical grids. Zero Industrial capitalizes on these market challenges by deploying thermal storage projects that will shift curtailed or off-peak clean electricity to baseload heat and steam used by industries globally.”

Zero Industrial is actively originating and developing projects in the United States and Canada and seeking industrial customers looking to decarbonize their industrial heat, eliminate criteria pollutants and reduce energy costs and volatility.

About Zero Industrial, Inc.

Zero Industrial is a leading developer of industrial decarbonization projects, utilizing thermal energy storage technologies to eliminate the combustion of fossil fuels for heat and steam production at industrial facilities. Zero Industrial offers its customers a full end-to-end development solution from design and engineering to project execution and delivery. Heat generated from its projects will be sold under a Heat-as-a-Service agreement without requiring any capital investment from its customers. Zero Industrial is actively originating and developing projects in the United States and Canada and exploring additional international markets. For more information, please visit www.zeroindustrial.energy

About Evok Innovations

Evok is a clean tech venture capital fund focused on supporting exceptional entrepreneurs with bold visions for scaling novel technologies within heavy industry. At Evok, we provide value beyond capital by leveraging our team of technologists and company builders, along with our limited partner group—which includes major financial institutions and industrial leaders—to help accelerate the success of our companies.

In 2016, Evok was founded with the thesis of collaborating with industrial partners to invest in and scale novel technologies in the energy sector. With the launch of Evok Fund II in 2022, we expanded this mandate, bringing in strategic partners across new industrial verticals, including critical minerals. Evok is actively investing out of Fund II, a $284M USD fund focused on supporting Series A+ companies in North America that are taking novel approaches to supporting the energy transition across a wide array of sectors and industries. For more information, please visit: www.evokinnovations.com

About Rusheen Capital Management

Rusheen Capital Management (“RCM”) is a Santa Monica-based private equity firm specializing in investments that promote sustainability and resource efficiency across the energy transition landscape. Founded in 2015, RCM focuses on growth-stage companies in sectors such as carbon capture and utilization, energy transition, low-carbon energy, and water sustainability. Since 2003, RCM’s principals founded, ran, and invested in over 40 energy transition companies across the entire industrial economy. For more information, please visit www.rusheen.com.

For more information, contact Sara Holba at info@zeroindustrial.energy

View original content to download multimedia:https://www.prnewswire.com/news-releases/zero-industrial-announces-10-million-series-a-investment-to-accelerate-development-of-thermal-energy-storage-in-north-america-302421563.html

SOURCE Zero Industrial, Inc.

Continue Reading

Technology

MakeWell Announces Free Access to AI-Driven Healthcare Companion App in Recognition of the WHO’s World Health Day

Published

on

By

SAVANNAH, Ga., April 7, 2025 /PRNewswire/ — In honor of the annual World Health Day, MakeWell, a pioneering AI healthcare start-up, is proud to announce that its AI-driven healthcare companion app is now available free of charge on the App Store and Google Play. This initiative aligns with MakeWell’s commitment to expanding access to critical healthcare information and resources, particularly for underserved populations worldwide.

In keeping with this year’s theme, “Healthy Beginnings, Hopeful Futures” MakeWell notes that approximately 300,000 women lose their lives during pregnancy or childbirth each year. The vast majority of these deaths occur in low resource settings due to preventable causes. MakeWell’s AI-powered app is designed to bridge healthcare gaps by providing real-time, personalized guidance on maternal health, chronic disease management, and general well-being. The MakeWell app supports 200+ languages, broadening its worldwide appeal.

“With the launch of our free app, we are taking a step toward making healthcare more accessible to everyone, regardless of geography or economic status,” said Daniel Carroll, Founder of MakeWell. “No one should lose their life due to a lack of medical knowledge or access to care. Our AI-driven platform empowers individuals, putting reliable, evidence-based health insights right at their fingertips.”

MakeWell’s app offers features such as symptom assessments, possible treatment/care options, preventative health recommendations, and connections to local healthcare resources. By leveraging advanced AI technology, it serves as a 24/7 digital health companion, supporting individuals in making informed medical decisions. The MakeWell app supports 200+ languages, broadening its worldwide appeal.

The MakeWell app is now available for free download in the App Store. To learn more about how MakeWell is working to create a healthier world, please visit us at www.makewell.ai 

View original content to download multimedia:https://www.prnewswire.com/news-releases/makewell-announces-free-access-to-ai-driven-healthcare-companion-app-in-recognition-of-the-whos-world-health-day-302418860.html

SOURCE MakeWell

Continue Reading

Trending